# KidneYou - Innovative Digital Therapy

> **NCT05286632** · NA · COMPLETED · sponsor: **Advice Pharma Group srl** · enrollment: 210 (actual)

## Conditions studied

- Chronic Kidney Diseases
- Diabetes
- Arterial Hypertension
- Chronic Glomerulonephritis
- Cystic Kidney Diseases
- Polycystic Kidney
- Nephronophthisis
- Cortical Cystic Disease
- Cystic Diseases
- Tuberous Sclerosis
- Albuminuria
- Treatment Adherence
- Treatment Adherence and Compliance

## Interventions

- **DEVICE:** KidneYou APP

## Key facts

- **NCT ID:** NCT05286632
- **Lead sponsor:** Advice Pharma Group srl
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-18
- **Primary completion:** 2024-06-28
- **Final completion:** 2024-07-31
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2024-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05286632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05286632, "KidneYou - Innovative Digital Therapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05286632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*